FDA Inspection 760785 — Central Pennsylvania Blood Bank

Central Pennsylvania Blood Bank — FEI 3005554295

The FDA completed an inspection of Central Pennsylvania Blood Bank on Nov 29, 2011 in Hanover, PA. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.

Inspection details

Classification
No Action Indicated (NAI)
End Date
Nov 29, 2011
Fiscal Year
2012
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Hanover, PA (United States)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.